Epstein Barr Virus News and Research

RSS
Epstein-Barr virus, frequently referred to as EBV, is a member of the herpesvirus family and one of the most common human viruses. The virus occurs worldwide, and most people become infected with EBV sometime during their lives. In the United States, as many as 95% of adults between 35 and 40 years of age have been infected. Infants become susceptible to EBV as soon as maternal antibody protection (present at birth) disappears. Many children become infected with EBV, and these infections usually cause no symptoms or are indistinguishable from the other mild, brief illnesses of childhood. In the United States and in other developed countries, many persons are not infected with EBV in their childhood years. When infection with EBV occurs during adolescence or young adulthood, it causes infectious mononucleosis 35% to 50% of the time.

Symptoms of infectious mononucleosis are fever, sore throat, and swollen lymph glands. Sometimes, a swollen spleen or liver involvement may develop. Heart problems or involvement of the central nervous system occurs only rarely, and infectious mononucleosis is almost never fatal. There are no known associations between active EBV infection and problems during pregnancy, such as miscarriages or birth defects. Although the symptoms of infectious mononucleosis usually resolve in 1 or 2 months, EBV remains dormant or latent in a few cells in the throat and blood for the rest of the person's life. Periodically, the virus can reactivate and is commonly found in the saliva of infected persons. This reactivation usually occurs without symptoms of illness.
Study Unveils Broader Immune Response in EBV-MS Connection

Study Unveils Broader Immune Response in EBV-MS Connection

NIH Researchers Map Vulnerable Sites on Epstein-Barr Virus gp42 Protein

NIH Researchers Map Vulnerable Sites on Epstein-Barr Virus gp42 Protein

EBV-Targeting T-Cells Linked to Early MS Damage

EBV-Targeting T-Cells Linked to Early MS Damage

Epstein-Barr Virus Epigenome Targeted for Potential Cancer Treatment

Epstein-Barr Virus Epigenome Targeted for Potential Cancer Treatment

Immune Deficits in Space are Temporary

Immune Deficits in Space are Temporary

Researchers Show How a Virus can Induce Cleavage of Human Chromosome 11 to Cause Cancer

Researchers Show How a Virus can Induce Cleavage of Human Chromosome 11 to Cause Cancer

Common Epstein-Barr virus may be a trigger for multiple sclerosis

Common Epstein-Barr virus may be a trigger for multiple sclerosis

Protein that facilitates cancer-causing viruses dodge the immune system

Protein that facilitates cancer-causing viruses dodge the immune system

Resistance against Epstein-Barr virus from experimental monoclonal antibodies

Resistance against Epstein-Barr virus from experimental monoclonal antibodies

Epstein-Barr virus reactivation likely to blame for long COVID symptoms

Epstein-Barr virus reactivation likely to blame for long COVID symptoms

TGen identifies genetic target that could help explain the variation in COVID-19 effects

TGen identifies genetic target that could help explain the variation in COVID-19 effects

EBV viral genome modifies the host epigenetic landscape to promote gastric cancer

EBV viral genome modifies the host epigenetic landscape to promote gastric cancer

Researchers comprehensively describe the 'human tissue virome atlas'

Researchers comprehensively describe the 'human tissue virome atlas'

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.